Key result
Preemptive aortic side branch embolization reduces the incidence of type II endoleak (OR 0.34) and promotes early aneurysm sac shrinkage after endovascular aneurysm repair, though its impact on rupture and mortality remains unclear.
Why the study?
Evidence for the effectiveness of preemptive side branch embolization in preventing rupture, reducing mortality, and ensuring safety and cost-effectiveness after endovascular aneurysm repair is limited.
Does preemptive aortic side branch embolization prevent type II endoleak and improve clinical outcomes in patients undergoing endovascular abdominal aneurysm repair?
Does preemptive aortic side branch embolization prevent type II endoleak and improve clinical outcomes in patients undergoing endovascular abdominal aneurysm repair?
Odds Ratio: 0.34 (95% CI 0.26–0.44)
Absolute Event Rate: 18.5% vs 38.6%
Preemptive aortic side branch embolization before EVAR reduces type II endoleaks and promotes sac shrinkage, but lacks high-quality evidence for improving hard clinical outcomes like rupture or mortality.
Preemptive side branch embolization may help prevent type II endoleak, reduce reintervention rates, and promote early aneurysm sac shrinkage after endovascular aneurysm repair. However, evidence of its effectiveness in preventing aneurysm rupture, reducing aneurysm-related mortality, ensuring safety, and maintaining cost-effectiveness is limited. The 2024 European Society for Vascular Surgery guidelines do not recommend routine preemptive embolization due to a lack of high-quality evidence. Concerns about radiation exposure and financial costs remain unresolved. Further research is needed to identify patients who would benefit most from preemptive embolization, as well as to evaluate its long-term impact on clinical outcomes, safety, and cost-effectiveness.
No takes yet. Share an insight, caveat, or question.
Gentsu et al. (2025) conducted a review in Abdominal aortic aneurysm undergoing endovascular aneurysm repair (EVAR). Preemptive aortic side branch embolization vs. No embolization was evaluated on Overall incidence of Type II endoleak (T2EL) (OR 0.34, 95% CI 0.26-0.44). Preemptive aortic side branch embolization reduces the incidence of type II endoleak (OR 0.34) and promotes early aneurysm sac shrinkage after endovascular aneurysm repair, though its impact on rupture and mortality remains unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: